North America Anti-Nuclear Antibody Test Market Analysis & Forecast to 2025 - ResearchAndMarkets.com

DUBLIN--()--The "North America Anti-Nuclear antibody test Market Analysis, Companies Profiles, Size, Share, Growth, Trends and Forecast to 2025" report has been added to ResearchAndMarkets.com's offering.

North America anti-nuclear antibody test market is expected to reach USD 920.96 million by 2025 from USD 520.46 million in 2017, at a CAGR of 7.5% in the forecast period 2018 to 2025.

The North America anti-nuclear antibody test market is segmented on the basis of product into assay kits & reagents, systems, and software. In 2018, assay kits & reagents is expected to dominate the North America anti-nuclear antibody test market with 52.0% market share and is expected to reach USD 485.67 million by 2025, with the highest CAGR of 7.7% in the forecast period 2018 to 2025.

The North America anti-nuclear antibody test market is segmented on the basis of test into indirect immunofluorescence, ELISA, and multiplex testing. In 2018, indirect immunofluorescence is expected to dominate the North America anti-nuclear antibody test market with 46.0% market share and is expected to reach USD 394.83 million by 2025, with the CAGR of 6.4% in the forecast period 2018 to 2025.

Companies Mentioned

  • Bio-Rad Laboratories, Inc.
  • Alere, Inc.
  • Trinity Biotech
  • Thermo Fisher Scientific Inc.
  • Antibodies Inc.
  • EUROIMMUN AG
  • Immuno Concepts

Key Topics Covered:

1. Introduction

2. Market Segmentation

3. Market Overview

4. Executive Summary

5. Premium Insights

6. North-America Anti-Nuclear Antibody Test Market, By Product

7. North-America Anti-Nuclear Antibody Test Market, By Test

8. North-America Anti-Nuclear Antibody Test Market, By Disease

9. North-America Anti-Nuclear Antibody Test Market, By End User

10. North-America Anti-Nuclear Antibody Test Market, By Geography

11. North-America Anti-Nuclear Antibody Test Market, Company Landscape

12. Company Profiles

13. Related Reports

For more information about this report visit https://www.researchandmarkets.com/research/nd4n2w/north_america?w=4

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T. Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Diagnostics, Oncology Drugs

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T. Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Diagnostics, Oncology Drugs